QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2016     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients 期刊论文 PANCREATOLOGY, 2016, 卷号: 16, 期号: 6 作者:  Cheng, He;  Luo, Guopei;  Lu, Yu;  Jin, Kaizhou;  Guo, Meng 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 Inflammation response  Neutrophil-lymphocyte ratio (NLR)  Regulatory T cells (Tregs)  Prognosis  Pancreatic cancer   Expression of GRP78, Master Regulator of the Unfolded Protein Response, Increases Chemoresistance in Pancreatic Ductal Adenocarcinoma 期刊论文 MOLECULAR CANCER THERAPEUTICS, 2016 Gifford, Jenifer B.; Huang, Wei; Zeleniak, Ann E.; Hindoyan, Antreas; Wu, Hong; Donahue, Timothy R.; Hill, Reginald 收藏  |  浏览/下载：10/0  |  提交时间：2017/12/03 RANDOMIZED CONTROLLED-TRIAL  HEPATOCELLULAR-CARCINOMA  ADJUVANT CHEMOTHERAPY  DRUG-RESISTANCE  ER STRESS  CANCER  GEMCITABINE  CELLS  INHIBITOR  SURVIVAL   The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients 会议论文 作者:  Chen, He;  Liu, Chen;  Luo, Guopei;  Lu, Yu;  Yu, Xianjun 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/06 Human equilibrative nucleoside transporter 1 as independent factor of good prognosis for resectable pancreatic cancer patients treated with gemcitabine-based regimen 期刊论文 Pancreatology, 2016 作者:  Di Y., Yu X., Li J., Yang F., Li H., Hao S., Ouyang Q., Fu D., Jin C. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/06